Exact Mass: 441.2951044

Exact Mass Matches: 441.2951044

Found 243 metabolites which its exact mass value is equals to given mass value 441.2951044, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lisinopril dihydrate

Lisinopril hydrate (JP18)

C21H31N3O5. 2H2O (441.24748800000003)


Therapeutic category: 2144 2179

   

Perindopril erbumine

Perindopril erbumine

C23H43N3O5 (441.32025480000004)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Perindopril erbumine is an angiotensin-converting enzyme inhibitor. Perindopril erbumine modulates NF-κB and STAT3 signaling and inhibits glial activation and neuroinflammation. Perindopril erbumine can be used for the research of Chronic Kidney Disease and high blood pressure[1][2][3][4].

   

Leukotriene E3

[5S-[5R*,6S*(s*),7E,9E,11Z]]-6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11-eicosatrienoic acid

C23H39NO5S (441.25488040000005)


Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)

   

N-Arachidonoyl Histidine

2-(icosa-5,8,11,14-tetraenamido)-3-(1H-imidazol-5-yl)propanoic acid

C26H39N3O3 (441.2991264)


N-arachidonoyl histidine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Histidine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Histidine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Histidine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Isoleucine

2-[(1-Hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene)amino]-3-methylpentanoate

C28H43NO3 (441.3242768)


N-docosahexaenoyl isoleucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Isoleucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Isoleucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Isoleucine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Leucine

2-[(1-Hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene)amino]-4-methylpentanoate

C28H43NO3 (441.3242768)


N-docosahexaenoyl leucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Leucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Leucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Leucine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Pentanoic acid, 5-(dipentylamino)-5-oxo-4-((3-quinolinylcarbonyl)amino)-, (R)-

Pentanoic acid, 5-(dipentylamino)-5-oxo-4-((3-quinolinylcarbonyl)amino)-, (R)-

C25H35N3O4 (441.26274300000006)


   

4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol

5-hydroxy-2,6,15-trimethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-ene-6-carboxylate

C29H45O3 (441.336852)


4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as nutmeg, common persimmon, common salsify, and lemon thyme, which makes 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol

5-hydroxy-2,15-dimethyl-14-(6-methyl-5-methylideneheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-ene-6-carboxylate

C29H45O3 (441.336852)


4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol can be found in a number of food items such as wild celery, common cabbage, watermelon, and chestnut, which makes 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

12-Acetyldehydrolucidusculine

Dehydrolucidusculine 12-acetate

C26H35NO5 (441.25151000000005)


   

R-1 Methanandamide phosphate

N-(2-phosphate-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide

C23H40NO5P (441.2643960000001)


   

(20R*,22R*)-N-methyl-5,6,12,13-tetrahydro-3beta,23beta-dihydroxy-5alpha,13beta,17beta,25alpha-veratraman-7,12(14)-dien-6-one|puqienine E

(20R*,22R*)-N-methyl-5,6,12,13-tetrahydro-3beta,23beta-dihydroxy-5alpha,13beta,17beta,25alpha-veratraman-7,12(14)-dien-6-one|puqienine E

C28H43NO3 (441.3242768)


   
   
   
   

(2RS,3SR,3RS,3aSR,6SR,6aSR,6bSR,7aRS,11aSR,11bRS)-1,2,3,3a,4,4,5,6,6,6a,6b,7,7,7a,8,11,11a,11b-octadecahydro-7a-methoxy-3,6,10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2(3H)-furo[3,2-b]pyridin]-3-ol|23-methoxycyclopamine

(2RS,3SR,3RS,3aSR,6SR,6aSR,6bSR,7aRS,11aSR,11bRS)-1,2,3,3a,4,4,5,6,6,6a,6b,7,7,7a,8,11,11a,11b-octadecahydro-7a-methoxy-3,6,10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2(3H)-furo[3,2-b]pyridin]-3-ol|23-methoxycyclopamine

C28H43NO3 (441.3242768)


   
   

(13R)-11alpha-acetoxy-2alpha-hydroxy-13-isobutyryloxyhetisane|trichodelphinine A

(13R)-11alpha-acetoxy-2alpha-hydroxy-13-isobutyryloxyhetisane|trichodelphinine A

C26H35NO5 (441.25151000000005)


   

(S,S)-ciliatamide A|ciliatamide A|N-methyl-((S)-azepan-2-one-3-ylamino-(S)-oxo-3-phenylpropan-2-yl)dec-9-enamide

(S,S)-ciliatamide A|ciliatamide A|N-methyl-((S)-azepan-2-one-3-ylamino-(S)-oxo-3-phenylpropan-2-yl)dec-9-enamide

C26H39N3O3 (441.2991264)


   
   

Ala Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Ala Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Ala Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Ala Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Ala Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Ala Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Gly Ile Pro Arg

(2S)-2-{[(2S)-1-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Ile Arg Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Gly Leu Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Leu Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Gly Pro Ile Arg

(2S)-2-[(2S,3S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Pro Leu Arg

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Pro Arg Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Pro Arg Leu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Arg Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Gly Arg Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Gly Arg Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Gly Arg Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Ile Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Ile Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Ile Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Ile Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Ile Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Ile Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Ile Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Ile Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Ile Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Ile Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C19H35N7O5 (441.26995400000004)


   

Ile Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Ile Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Lys Pro Pro Thr

(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H35N5O6 (441.25872100000004)


   

Lys Pro Thr Pro

(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Lys Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Lys Thr Pro Pro

(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Lys Val Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Lys Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H39N5O5 (441.2951044)


   

Leu Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Leu Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Leu Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Leu Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Leu Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Leu Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Leu Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Leu Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Leu Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Leu Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C19H35N7O5 (441.26995400000004)


   

Leu Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Leu Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Ile Pro Val

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Ile Val Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Asn Leu Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Leu Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Asn Pro Ile Val

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Pro Leu Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Pro Val Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Pro Val Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Val Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Asn Val Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Asn Val Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Asn Val Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Ala Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Ala Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Gly Ile Arg

(2S)-5-carbamimidamido-2-[(2S,3S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Gly Leu Arg

(2S)-5-carbamimidamido-2-[(2S)-4-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Gly Arg Ile

(2S,3S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Gly Arg Leu

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Ile Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Ile Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Ile Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Pro Ile Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]propanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Lys Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Lys Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Pro Lys Val Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Pro Leu Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Leu Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Leu Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Pro Leu Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]propanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Asn Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Asn Leu Val

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Asn Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Asn Val Leu

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Pro Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]-3-hydroxybutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Pro Thr Lys

(2S)-6-amino-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]hexanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Gln Val Val

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Arg Ala Val

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Arg Gly Ile

(2S,3S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Arg Gly Leu

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Arg Ile Gly

2-[(2S,3S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylpentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Pro Arg Leu Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-4-methylpentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Pro Arg Val Ala

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]propanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Thr Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Pro Thr Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Ala Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]pentanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Val Ile Asn

(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]propanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Pro Val Leu Asn

(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]propanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Asn Ile

(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Asn Leu

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Gln Val

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Pro Val Arg Ala

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]propanoic acid

C19H35N7O5 (441.26995400000004)


   

Pro Val Val Lys

(2S)-6-amino-2-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]hexanoic acid

C21H39N5O5 (441.2951044)


   

Pro Val Val Gln

(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]butanoic acid

C20H35N5O6 (441.25872100000004)


   

Gln Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Gln Val Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Gln Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Arg Ala Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Ala Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Gly Ile Pro

(2S)-1-[(2S,3S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Gly Leu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Gly Pro Ile

(2S,3S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Gly Pro Leu

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Ile Gly Pro

(2S)-1-{2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Ile Pro Gly

2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C19H35N7O5 (441.26995400000004)


   

Arg Leu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Leu Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Ala Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylbutanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Gly Ile

(2S,3S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Gly Leu

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-methylpentanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Ile Gly

2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Leu Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]acetic acid

C19H35N7O5 (441.26995400000004)


   

Arg Pro Val Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]propanoic acid

C19H35N7O5 (441.26995400000004)


   

Arg Val Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Arg Val Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H35N7O5 (441.26995400000004)


   

Thr Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Thr Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Thr Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Ala Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Val Ala Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Val Ile Asn Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Val Ile Pro Asn

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Lys Pro Val

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Val Lys Val Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H39N5O5 (441.2951044)


   

Val Leu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Val Leu Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Asn Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Val Asn Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Val Asn Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Asn Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Ala Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-5-carbamimidamidopentanoic acid

C19H35N7O5 (441.26995400000004)


   

Val Pro Ile Asn

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Lys Val

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylbutanoic acid

C21H39N5O5 (441.2951044)


   

Val Pro Leu Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-carbamoylpropanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Asn Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Asn Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-4-methylpentanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Gln Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Pro Arg Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]propanoic acid

C19H35N7O5 (441.26995400000004)


   

Val Pro Val Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]hexanoic acid

C21H39N5O5 (441.2951044)


   

Val Pro Val Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-carbamoylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Gln Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Gln Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Val Arg Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H35N7O5 (441.26995400000004)


   

Val Arg Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H35N7O5 (441.26995400000004)


   

Val Val Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C21H39N5O5 (441.2951044)


   

Val Val Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C21H39N5O5 (441.2951044)


   

Val Val Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C20H35N5O6 (441.25872100000004)


   

Val Val Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C20H35N5O6 (441.25872100000004)


   

Leukotriene E3

[5S-[5R*,6S*(s*),7E,9E,11Z]]-6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11-eicosatrienoic acid

C23H39NO5S (441.25488040000005)


A leukotriene that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond.

   

cyclopropyl methyl amide

N-ethyl-9,11,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-cyclopropyl methyl amide

C27H39NO4 (441.28789340000003)


   

N-(α-Linolenoyl) Tyrosine

N-(L-tyrosine)-9Z,12Z,15Z-octadecatrienamide

C27H39NO4 (441.28789340000003)


   

Boc-Pro-DVal(NMe)-Val-OMe

Boc-Pro-DVal(NMe)-Val-OMe

C22H39N3O6 (441.2838714)


   

N-arachidonoyl histidine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-histidine

C26H39N3O3 (441.2991264)


   

DGLA dopamine

N-(8Z,11Z,14Z-eicosatrienoyl) dopamine

C28H43NO3 (441.3242768)


   

LPE O-15:0;O

1-(2-methoxy-tetradecanyl)-sn-glycero-3-phosphoethanolamine

C20H44NO7P (441.28552440000004)


   

[1,1-Bis(hydroxymethyl)-3-(4-octylphenyl)propyl]carbamic acid Phenylmethyl Ester

[1,1-Bis(hydroxymethyl)-3-(4-octylphenyl)propyl]carbamic acid Phenylmethyl Ester

C27H39NO4 (441.28789340000003)


   

PHENOL, 2-(2H-BENZOTRIAZOL-2-YL)-6-(1-METHYL-1-PHENYLETHYL)-4-(1,1,3,3-TETRAMETHYLBUTYL)-

PHENOL, 2-(2H-BENZOTRIAZOL-2-YL)-6-(1-METHYL-1-PHENYLETHYL)-4-(1,1,3,3-TETRAMETHYLBUTYL)-

C29H35N3O (441.277998)


   

2-(dimethylamino)ethyl 2-methylprop-2-enoate,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate

2-(dimethylamino)ethyl 2-methylprop-2-enoate,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate

C24H43NO6 (441.30902180000004)


   

3-Hydroxy-piperidine-1-carboxylic acid tert-butyl ester

3-Hydroxy-piperidine-1-carboxylic acid tert-butyl ester

C30H35NO2 (441.266765)


   
   

Ciliatamide A

Ciliatamide A

C26H39N3O3 (441.2991264)


A lipopeptide that contains N-methylphenylalanine and lysine as the amino acid residues linked to a dec-9-enoyl moiety via an amide linkage (the R,R stereoisomer). It is isolated from the deep sea sponge Aaptos ciliata and exhibits antileishmanial activity.

   

5-Methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-ylcarbamoyl)-hexanoic acid

5-Methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-ylcarbamoyl)-hexanoic acid

C25H35N3O4 (441.26274300000006)


   

Lisinopril diydrate

Lisinopril dihydrate

C21H35N3O7 (441.24748800000003)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents

   

4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol

5-hydroxy-2,6,15-trimethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-ene-6-carboxylate

C29H45O3 (441.336852)


4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as nutmeg, common persimmon, common salsify, and lemon thyme, which makes 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products. 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol can be found in a number of food items such as nutmeg, common persimmon, common salsify, and lemon thyme, which makes 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol a potential biomarker for the consumption of these food products.

   

4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol

5-hydroxy-2,15-dimethyl-14-(6-methyl-5-methylideneheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-ene-6-carboxylate

C29H45O3 (441.336852)


4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol can be found in a number of food items such as wild celery, common cabbage, watermelon, and chestnut, which makes 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol a potential biomarker for the consumption of these food products. 4α-carboxy-ergosta-7,24(241)-dien-3β-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4α-carboxy-ergosta-7,24(241)-dien-3β-ol can be found in a number of food items such as wild celery, common cabbage, watermelon, and chestnut, which makes 4α-carboxy-ergosta-7,24(241)-dien-3β-ol a potential biomarker for the consumption of these food products.

   

4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol

3-Hydroxy-4,10,13-trimethyl-17-(6-methylhept-5-en-2-yl)-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylate

C29H45O3- (441.336852)


4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as nutmeg, common persimmon, common salsify, and lemon thyme, which makes 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol

3-hydroxy-10,13-dimethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylate

C29H45O3- (441.336852)


4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol can be found in a number of food items such as wild celery, common cabbage, watermelon, and chestnut, which makes 4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

4beta-Methylzymosterol-4alpha-carboxylate

4beta-Methylzymosterol-4alpha-carboxylate

C29H45O3- (441.336852)


A steroid acid anion that is the conjugate base of 4beta-methylzymosterol-4alpha-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol

4alpha-carboxy-ergosta-7,24(241)-dien-3beta-ol

C29H45O3- (441.336852)


   

4beta-Carboxy-4alpha-methyl-5alpha-cholesta-8,24-dien-3beta-ol

4beta-Carboxy-4alpha-methyl-5alpha-cholesta-8,24-dien-3beta-ol

C29H45O3- (441.336852)


   

3-Oxo-24-ethyl-cholest-4-en-26-oate

3-Oxo-24-ethyl-cholest-4-en-26-oate

C29H45O3- (441.336852)


   
   

4alpha-carboxy-ergosta-8,25(27)-dienol

4alpha-carboxy-ergosta-8,25(27)-dienol

C29H45O3- (441.336852)


   

N-Docosahexaenoyl Isoleucine

N-Docosahexaenoyl Isoleucine

C28H43NO3 (441.3242768)


   

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

C26H39N3O3 (441.2991264)


   

2-[[(4E,7E,10E,13E,16E,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-4-methylpentanoic acid

2-[[(4E,7E,10E,13E,16E,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-4-methylpentanoic acid

C28H43NO3 (441.3242768)


   
   

Militarinone E, (rel)-

Militarinone E, (rel)-

C26H35NO5 (441.25151000000005)


A natural product found in Isaria farinosa.

   

Militarinone F, (rel)-

Militarinone F, (rel)-

C26H35NO5 (441.25151000000005)


A natural product found in Isaria farinosa.

   

Lys-Thr-Pro-Pro

Lys-Thr-Pro-Pro

C20H35N5O6 (441.25872100000004)


A tetrapeptide composed of L-lysine, L-threonine and two L-proline units joined in sequence by peptide linkages.

   

3alpha,7alpha-Dihydroxy-5beta-cholane-24-sulfonate

3alpha,7alpha-Dihydroxy-5beta-cholane-24-sulfonate

C24H41O5S- (441.26745560000006)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C25H35N3O4 (441.26274300000006)


   

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C25H35N3O4 (441.26274300000006)


   

(2R,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2R,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

C25H35N3O4 (441.26274300000006)


   

(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C25H35N3O4 (441.26274300000006)


   

(2S,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2S,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

C25H35N3O4 (441.26274300000006)


   

(2E)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadec-2-enoate

(2E)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadec-2-enoate

C25H45O6- (441.321597)


   

(E,18R)-18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynonadec-2-enoate

(E,18R)-18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynonadec-2-enoate

C25H45O6- (441.321597)


   

Terbutaline, tris(trimethylsilyl)ether

Terbutaline, tris(trimethylsilyl)ether

C21H43NO3Si3 (441.2550608)


   

2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(ethylamino)ethyl]-3-pyridinecarboxamide

2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(ethylamino)ethyl]-3-pyridinecarboxamide

C20H39N3O4Si2 (441.24789740000006)


   
   

Dihomo-gamma-linolenoyl dopamine

Dihomo-gamma-linolenoyl dopamine

C28H43NO3 (441.3242768)


   

ascr#33(1-)

ascr#33(1-)

C25H45O6 (441.321597)


Conjugate base of ascr#33

   

oscr#33(1-)

oscr#33(1-)

C25H45O6 (441.321597)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#33, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

NA-Dopamine 20:3(8Z,11Z,14Z)

NA-Dopamine 20:3(8Z,11Z,14Z)

C28H43NO3 (441.3242768)


   

NA-His 20:4(5Z,8Z,11Z,14Z)

NA-His 20:4(5Z,8Z,11Z,14Z)

C26H39N3O3 (441.2991264)


   

NA-Ile 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Ile 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C28H43NO3 (441.3242768)


   

NA-Leu 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Leu 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C28H43NO3 (441.3242768)


   
   
   
   
   
   
   
   
   
   

(1r,2r,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(1r,2r,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C26H35NO5 (441.25151000000005)


   

1,4-dihydroxy-5-(4-hydroxycyclohex-1-en-1-yl)-3-(6,8,10-trimethyldodeca-2,4,6-trienoyl)pyridin-2-one

1,4-dihydroxy-5-(4-hydroxycyclohex-1-en-1-yl)-3-(6,8,10-trimethyldodeca-2,4,6-trienoyl)pyridin-2-one

C26H35NO5 (441.25151000000005)


   

(1r,2r,4s,5r,8s,10r,12r,13s,14r,16s,17r,19s)-16-(acetyloxy)-11-ethyl-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

(1r,2r,4s,5r,8s,10r,12r,13s,14r,16s,17r,19s)-16-(acetyloxy)-11-ethyl-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

C26H35NO5 (441.25151000000005)